Novo Nordisk reported DKK34.08B in EBIT for its fiscal quarter ending in June of 2025.





Ebit Change Date
Bausch Health Companies USD 717M 112M Sep/2025
Bristol-Myers Squibb USD 4.04B 1.78B Sep/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
GlaxoSmithKline GBP 2.79B 716M Sep/2025
Merck USD 7.56B 1.19B Sep/2025
Novartis USD -9.19B 13.87B Jun/2025
Novo Nordisk DKK 34.08B 4.71B Jun/2025
Novo Nordisk DKK 5.18B 37.04B Jun/2025
Pacira USD 13.15M 2.92M Sep/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Supernus Pharmaceuticals USD -60.18M 72.33M Sep/2025